Shopping Cart
Remove All
Your shopping cart is currently empty
5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
![5-Bromoimidazo[1,2-A]Pyrazine](https://cdn.targetmol.com/group3/M00/03/36/CgoaEGY7SlyED42UAAAAAKKAz30025.png)
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $82 | - | In Stock | |
| 5 mg | $181 | - | In Stock | |
| 10 mg | $267 | - | In Stock | |
| 25 mg | $413 | - | In Stock | |
| 50 mg | $571 | - | In Stock | |
| 100 mg | $763 | - | In Stock | |
| 200 mg | $1,030 | - | In Stock |
| Description | 5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro. |
| Molecular Weight | 198.02 |
| Formula | C6H4BrN3 |
| Cas No. | 87597-26-0 |
| Smiles | BrC1=CN=CC2=NC=CN12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (252.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.